We rounded up thoughts on why 88% plan to increase their third-party technology investments in 2023-2024 according to a Redox sponsored survey, Buyer Mindsets: Health Technology Perspectives from Clinical and Clinical IT Leaders.
Read More
Projections of National Health Expenditures and health insurance enrollment have been released for the years 2022-2031. We wanted to know how health tech can help reduce US healthcare spending and positively impact the forecasts? Here are the answers we received.
My friends in PR land sent me a lot of emails highlighting their clients and what they were doing at HIMSS next week. I know I can’t go to them all but I thought these were interesting topics to share. Hope you can check some out. See you in Chicago.
Will using AI in healthcare to analyze collected personal health data for better outcomes prove to be meaningful in 2023? More predictions on AI in 2023.
Will we continue to make progress and implement initiatives that right the ship in 2023 when it comes to the population’s health and equity of care? Here are some predictions from the industry.
With the reporting of 26,000 attendees, HIMSS seems to be getting back on track and moving in the right direction. So what were the reactions? What were the takeaways? Will the exhibitors and attendees return next year? Here is what they told us.
This month for our roundup on health IT marketing we decided to round up our marketing experts and tell us what we might see in the new year. Here is what we found out.
As 2021 comes to an end we like to reach out to our thought leaders to see what they think we can expect next year. So what should we look forward to when it comes to Big Data, Analytics, and AI in health IT?
This is our ongoing reporting on how AI is being integrated into healthcare technology. We are seeking out the thought leaders and innovations that are moving the needle forward which include Jvion, Black Book Research, Sensyne Health, Great Ormond Street Hospital, Swoop, Dosis, Prevencio, Inc., OncoHost, and RSIP Vision.